期刊文献+

老年急性髓细胞性白血病化疗方案及其疗效分析

Clinical Observation of 34 Acute Myeloid Leukemia in the Elderly
下载PDF
导出
摘要 【目的】探讨老年急性髓细胞性白血病的有效治疗方案。【方法】个体化中、小剂量联合化疗方案治疗老年急性髓细胞性白血病34例,总结其有效率及生存时间,并与国外相关资料进行比较。【结果】本院个体化中、小剂量联合化疗方案的有效率为70.4%,低于国外报道的79.0%,而平均生存期为228 d,高于国外报道的180 d。【结论】老年急性髓细胞性白血病的治疗需比较具体的个体化综合治疗方案。 [Objective]To explore of the efficient treating method for acute myeloid leukemia in the elderly. [Methods]Middle doses combined with low doses chemotherapy were individualizedly used to treat acute myeloid leukemia in the 34 elderly cases. Efficiency and time of survival were compared with foreign reports. [Results]The efficient rate of middle dose combined with low dose chemotherapy was 70. 4%,lower than foreign reports,the average survival time was 228 days, higher than foreign reports. [Conclusion]The combined and individualized chemotherapy for the acute myeloid leukemia in the elderly could be an ideal choice.
出处 《医学临床研究》 CAS 2006年第4期560-561,共2页 Journal of Clinical Research
关键词 白血病 粒细胞 急性/药物疗法 leukemia,myelocytic,acute/DT
  • 相关文献

参考文献6

  • 1沈志祥主编..血液科新进展[M].北京:人民卫生出版社,2000:449.
  • 2Roberto L,Maria CP,Franco M.Acute myeloid Leukemia in the elderly:per aspera ad astra[J]?Leukemia Research,1999,23:603-613. 被引量:1
  • 3Leith CP,Kopecky KJ,Godwin J.Acute myeloid leukemia in the elderly:Assessment of multidrug resistance(MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy:a Southwest Oncology Group Study[J].Blood,1997,89:3323. 被引量:1
  • 4Manoharam A.Acute myeloblastic leukemia in the elderly:biology,prognostic factors and treatment[J].Int J Hematol,1998,68(3):235-243. 被引量:1
  • 5Schiller GJ.Postremission therapy of acute myeloid leukemia in older adults[J].Leukemia,1996;10(Suppl 1):518-520. 被引量:1
  • 6顾惜春,朱玲,杨晓云,段红梅,范云.老年人急性非淋巴细胞白血病化疗疗效观察[J].临床血液学杂志,1999,12(4):168-169. 被引量:4

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部